Skip to content
10-K

Annual Report

Chinook Therapeutics, Inc.

0001564590-23-002589

← back to feed
Filed
Feb 27, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Feb 17, 2023 65.85M sh
Shares Diluted FY 2022 · Dec 31, 2022 64.37M sh
Shares Diluted FY 2022 · Dec 31, 2021 45.61M sh
Shares Diluted FY 2022 · Dec 31, 2020 13.17M sh
Capex FY 2022 · Dec 31, 2022 $1.65M
Capex FY 2022 · Dec 31, 2021 $1.88M
Capex FY 2022 · Dec 31, 2020 $797K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$117.48M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$102.74M
Operating Cash Flow FY 2022 · Dec 31, 2020 −$55.85M
Cash And Equivalents FY 2022 · Dec 31, 2022 $115.44M
Cash And Equivalents FY 2022 · Dec 31, 2021 $181.72M
Cash And Equivalents FY 2022 · Dec 31, 2020 $187.75M
Stockholders Equity FY 2022 · Dec 31, 2022 $441.94M
Stockholders Equity FY 2022 · Dec 31, 2021 $453.64M
Stockholders Equity FY 2022 · Dec 31, 2020 $334.62M
Stockholders Equity restated FY 2022 · Dec 31, 2019 −$41.12M
Current Liabilities FY 2022 · Dec 31, 2022 $50.84M
Current Liabilities FY 2022 · Dec 31, 2021 $40.09M
Total Liabilities FY 2022 · Dec 31, 2022 $132.14M
Total Liabilities FY 2022 · Dec 31, 2021 $110.16M
Current Assets FY 2022 · Dec 31, 2022 $385.59M
Current Assets FY 2022 · Dec 31, 2021 $300.64M
Total Assets FY 2022 · Dec 31, 2022 $574.08M
Total Assets FY 2022 · Dec 31, 2021 $563.8M
Eps Diluted FY 2022 · Dec 31, 2022 −$2.92
Eps Diluted FY 2022 · Dec 31, 2021 −$2.26
Eps Diluted FY 2022 · Dec 31, 2020 −$6.20
Eps Basic FY 2022 · Dec 31, 2022 −$2.92
Eps Basic FY 2022 · Dec 31, 2021 −$2.26
Eps Basic FY 2022 · Dec 31, 2020 −$6.20
Sga Expense FY 2022 · Dec 31, 2022 $36.29M
Sga Expense FY 2022 · Dec 31, 2021 $31.9M
Sga Expense FY 2022 · Dec 31, 2020 $19.07M
Rd Expense FY 2022 · Dec 31, 2022 $141.21M
Rd Expense FY 2022 · Dec 31, 2021 $96.99M
Rd Expense FY 2022 · Dec 31, 2020 $36.05M
Net Income FY 2022 · Dec 31, 2022 −$187.87M
Net Income FY 2022 · Dec 31, 2021 −$102.94M
Net Income FY 2022 · Dec 31, 2020 −$81.62M
Operating Income FY 2022 · Dec 31, 2022 −$185.08M
Operating Income FY 2022 · Dec 31, 2021 −$99.04M
Operating Income FY 2022 · Dec 31, 2020 −$56.23M
Revenue FY 2022 · Dec 31, 2022 $6.13M
Revenue FY 2022 · Dec 31, 2021 $51.63M
Revenue FY 2022 · Dec 31, 2020 $827K